Document Detail


Induction of pro-apoptotic and cell cycle-inhibiting genes in chromium (VI)-treated human lung fibroblasts: lack of effect of ERK.
MedLine Citation:
PMID:  14971655     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cell proliferation and apoptosis are controlled by tightly orchestrated signaling pathways that culminate in transcriptional activation/repression of multiple proteins. Dysregulation of cell cycle and/or apoptosis control may lead to genomic instability, neoplastic transformation and tumor progression. Under certain conditions, some hexavalent chromium [Cr(VI)] compounds are toxic and carcinogenic in the human respiratory tract, and we have shown that they induce apoptosis and/or cell cycle arrest in a p53-dependent fashion. There is increasing evidence linking extracellular signal-regulated kinase (ERK) activation with the DNA damage response, by both p53-dependent and -independent mechanisms. Here, the aim was to study the effect of Cr(VI) transcriptional regulation of key cell cycle inhibitors and pro- and anti-apoptotic proteins, as well as the role of ERK activation in the Cr(VI) genotoxic response. Diploid human lung fibroblasts were incubated with 3-9 uM Na2CrO4, and RNA was isolated at 4, 8, and 24 h, as well as 24 h after Cr(VI) exposure was terminated (recovery). mRNA expression was quantitated by RNase protection assay with a 32P-labeled multi-transcript probe containing gene sequences for the cdk inhibitors, p21waf1/cip1, p27kip1, p16INK4a, p15INK4b; the pro-apoptotic proteins bcl-XS and bax; the anti-apoptotic proteins bcl-W, bcl-XL, and bcl2, GADD45, and cyclin A. In general, bcl-W and bcl-XL expression were both downregulated after Cr exposure, to around 50% at 24 h, which was more pronounced after the recovery period. At Cr(VI) concentrations < or = 6 uM, bcl2 expression was upregulated. Of particular interest is that bax expression was reduced, in a dose and time-dependent fashion, however that of bcl-XS was elevated by nearly 3-fold after 8 h, and declined to control levels at the end of the recovery period. Expression of GADD45 and p21 were both upregulated by 2-fold at 8 h, but declined to control levels during recovery. Neither the expression of p27 nor that of p16 were apparently affected by Cr(VI) exposure, however the expression of p15 was markedly increased after exposure to all concentrations of Cr(VI). Finally, the expression of cyclin A was decreased after 24 h Cr(VI) exposure. Cr(VI) induced a transient burst of ERK activity (2-6-fold over control) around 0.5-3 h after exposure. However, inhibition of ERK activation with PD98059 had no effect on the Cr-induced alterations in gene expression. Moreover, Cr(VI)-induced clonogenic lethality, as assessed after 24 h exposure to 1 and 2 uM Cr(VI), was also not affected by ERK inhibition. These data suggest that both p53-dependent and -independent apoptotic and growth-inhibitory pathways are markedly affected by Cr(VI) exposure. However, the ability of Cr(VI) to affect key apoptotic and growth arresting genes, and thus clonogenic lethality, appears to be independent of ERK. Continued investigation into the cellular and molecular mechanisms of Cr(VI)-induced cell cycle and apoptosis control should further the understanding of Cr(VI)-associated carcinogenesis.
Authors:
Susan Ceryak; Carla Zingariello; Travis O'Brien; Steven R Patierno
Related Documents :
10100715 - Mechanisms of methotrexate resistance in osteosarcoma.
14741615 - Effect of cobalt and chromium ions on bcl-2, bax, caspase-3, and caspase-8 expression i...
15038405 - Bcl-2 expression and other clinicopathologic parameters in uterine leiomyosarcoma.
16785605 - Effects of long-term adrenalectomy on apoptosis and neuroprotection in the rat hippocam...
2361015 - Cloning and expression of cdna and genomic clones encoding three delayed rectifier pota...
23493985 - Decreased tissue and serum expression of galectin-7 in patients with hypertrophic scars.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Molecular and cellular biochemistry     Volume:  255     ISSN:  0300-8177     ISO Abbreviation:  Mol. Cell. Biochem.     Publication Date:  2004 Jan 
Date Detail:
Created Date:  2004-02-19     Completed Date:  2004-09-14     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0364456     Medline TA:  Mol Cell Biochem     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  139-49     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, The George Washington University Medical Center, Washington, DC 20037, USA. phmsmc@gwumc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apoptosis / drug effects*
Carcinogens, Environmental / pharmacology*
Child
Chromium / pharmacology*
Fibroblasts / drug effects,  metabolism*
Gene Expression Regulation / drug effects*
Genes, cdc / physiology
Humans
MAP Kinase Signaling System / drug effects*
Male
Mitogen-Activated Protein Kinases / metabolism*
Phosphorylation / drug effects
RNA, Messenger / drug effects,  metabolism
Grant Support
ID/Acronym/Agency:
ES05304/ES/NIEHS NIH HHS; ES0996/ES/NIEHS NIH HHS
Chemical
Reg. No./Substance:
0/Carcinogens, Environmental; 0/RNA, Messenger; 18540-29-9/chromium hexavalent ion; 7440-47-3/Chromium; EC 2.7.11.24/Mitogen-Activated Protein Kinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  NF-kappaB prevents cells from undergoing Cr(VI)-induced apoptosis.
Next Document:  Mechanisms of chromium-induced suppression of RNA synthesis in cellular and cell-free systems: relat...